Personalized Treatment of Refractory BPPV — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Personalized Treatment of Refractory BPPV — Stella

Recruiting

Back to Benign Paroxysmal Positional Vertigo trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Spain

Hospital Clínico Universitario, Santiago de Compostela, A Coruña

Key details

Sponsor

Hospital Clinico Universitario de Santiago

Collaborators

Instituto de Salud Carlos III, European Union

Enrollment target

~54 participants

Started

July 2024

Primary completion

June 2026

Age range

18 Years – 100 Years

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov